MSK physician-scientists Dr. Viviane Tabar and Dr. Lorenz Studer have developed a treatment for Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them ...

Research at MSK Our research impact Research topics Core facilities & resources ...

The Mortimer B. Zuckerman Research Center houses a number of research programs of the Sloan Kettering Institute and Memorial Hospital, as well as the Gerstner Sloan Kettering Graduate School of ...

If this is the case for you, we hope that you’ll take advantage of our specialized Adult Long-Term Follow-Up Program, which functions as a part of our Adult Survivorship Program. Through this clinic, ...

Physician-scientist Liang Deng studies poxvirus interface with the immune system and the development of poxviruses as oncolytic and immunotherapy for cancers.

This information explains how to insert your catheter to drain your urine (pee). A catheter is a flexible tube that drains urine from your bladder. You’ll insert your catheter yourself by placing it ...

This information explains cardiomyopathy caused by chemotherapy, including its signs, how it’s diagnosed, and how it’s treated.

There are more than 125 different types of brain cancer. Most brain tumors fall into one of two categories: high grade (rapidly growing) or low grade (slow growing). At Memorial Sloan Kettering, we ...

If you have questions or concerns, contact your healthcare provider. A member of your care team will answer Monday through Friday from 9 a.m. to 5 p.m. Outside those hours, you can leave a message or ...

Stem cell transplants, also called bone marrow transplants, can treat certain blood cancers. These include leukemia, lymphoma, and multiple myeloma. Learn what makes Memorial Sloan Kettering one of ...

MSK’s screening guidelines for prostate cancer Talk with your healthcare provider about your risk for prostate cancer and when screening is right for you. If you decide to have prostate cancer ...

How many people get ONJ? Only a small number of people who take bisphosphonates or denosumab will develop ONJ. We do not know who will get it and who will not. For every 100 people who take these ...